| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Flagship Ventures Fund V, L.P. | 53% | $1,461,279 | 29,225,579 | Noubar Afeyan | 29 Dec 2024 | |||
| Flagship V VentureLabs Rx Fund, L.P. | 53% | 0% | $1,461,279 | -$96,158 | 29,225,579 | 0% | Noubar Afeyan | 03 Feb 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q2 | 0 | $0 | -$2,426 | 0 | |
| 2025 Q1 | 19,648 | $2,426 | -$35,238,959 | $0.0810 | 3 |
| 2024 Q4 | 47,281,697 | $35,253,886 | -$921,847 | $0.7456 | 50 |
| 2024 Q3 | 48,290,202 | $58,913,912 | -$6,028,874 | $1.22 | 52 |
| 2024 Q2 | 50,536,106 | $104,608,814 | -$2,414,395 | $2.07 | 65 |
| 2024 Q1 | 51,125,783 | $186,608,210 | +$3,636,101 | $3.65 | 67 |
| 2023 Q4 | 50,199,378 | $151,099,311 | +$1,340,397 | $3.01 | 61 |
| 2023 Q3 | 50,884,826 | $109,402,405 | -$616,441 | $2.15 | 55 |
| 2023 Q2 | 51,091,479 | $286,110,760 | +$4,782,079 | $5.60 | 56 |
| 2023 Q1 | 50,231,941 | $302,897,871 | +$45,561,659 | $6.03 | 54 |
| 2022 Q4 | 16,767,952 | $95,743,501 | +$387,360 | $5.71 | 45 |
| 2022 Q3 | 42,602,823 | $230,906,000 | +$907,245 | $5.42 | 37 |
| 2022 Q2 | 42,483,912 | $161,435,866 | -$5,643,294 | $3.80 | 43 |
| 2022 Q1 | 43,544,231 | $271,734,574 | +$3,785,851 | $6.24 | 49 |
| 2021 Q4 | 42,386,890 | $478,991,000 | +$9,706,127 | $11.33 | 42 |
| 2021 Q3 | 40,868,461 | $766,211,000 | +$766,210,851 | $18.85 | 42 |